Journals / Türkderm-Deri Hastalıkları ve Frengi Arşivi / 2008 / Cilt: 42 - Sayı: 4

HPV and Herpes Zoster vaccines

HPV ve Herpes Zoster aşıları

Pages
108–112
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The purpose of this review is to give some knowledge about the vaccines which were developed for these diseases.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Genital warts and Herpes Zoster are relatively frequent encountered diseases in dermatology practice.
📊
Key Findings & Data:Cervical cancers arealso caused by some spesific types of human papillomaviruses.
💡
Conclusion & Impact:The purpose of this review is to give some knowledge about the vaccines which were developed for these diseases.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Genital warts and Herpes Zoster are relatively frequent encountered diseases in dermatology practice. Cervical cancers arealso caused by some spesific types of human papillomaviruses. The purpose of this review is to give some knowledge about the vaccines which were developed for these diseases.

Özet

Genital siğiller ve Herpes Zoster dermatoloji pratiğinde sık karşılaştığımız hastalıklardandır. Servikal kanser de yine “human papilloma virus”ün belirli tipleri tarafından oluşturulur. Bu derlemenin amacı bahsedilen hastalıklara karşı geliştirilen aşılar hakkında bilgi vermektir.

🔖

Cite This Article

KARABUDAK, Ö., DOĞAN, B. (2022). HPV and Herpes Zoster vaccines. Türkderm-Deri Hastalıkları ve Frengi Arşivi, Cilt: 42 - Sayı: 4, 108–112. https://ajindex.com/articles/622097

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Urman CO, Gottlieb AB. New viral vaccines for dermatologic disease. J Am Acad Dermatol 2008;58:361-70
  2. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-27
  3. Bosch FX, de Sanjose S. Chapter 1: Human papillomavirus and cervical cancer burden and assessment of causality. J Natl Cancer Inst Monogr 2003;31:3-13
  4. Clifford G, Franceschi S, Diaz M, Munoz N, Villa LL. Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine 2006;24S3:326-34
  5. Persson G, Dahlof LG, Krantz I. Physical and psychological effects of anogenital warts on female patients. Sex Transm Dis 1993;20:10-3
  6. Lacey CJ, Lowndes CM, Shah KV. Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine 2006;24S3:35-41
  7. Cates W Jr. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel. Sex Transm Dis 1999;26:2-7
  8. Bekkers RL, Massuger LF, Bulten J, Melchers WJ. Epidemiological and clinical aspects of human papillomavirus detection in the prevention of cervical cancer. Rev Med Virol 2004;14:95-105
  9. Grussendorf-Conen EI, de Villiers EM, Gissmann L. Human papillomavirus genomes in penile smears of healthy men. Lancet 1986;2:1092
  10. Ley C, Bauer HM, Reingold A, Schiffman MH, Chambers JC, Tashiro CJ, et al. Determinants of genital human papillomavirus infection in young women. J Natl Cancer Inst 1991;83:997-1003
  11. Kjaer SK, Svare EI, Worm AM, Walboomers JM, Meijer CJ. Van der Brule AJ. Human papillomavirus infection in Danish female sex workers. Decreasing prevalence with age despite continuously high sexual activity. Sex Transm Dis 2000;27:438-45
  12. Persson G, Andersson K, Krantz I. Symptomatic genital papillomavirus infection in a community. Incidence and clinical picture. Acta Obstet Gynecol Scand 1996;75:287-90
  13. Conley LJ, Ellerbrock TV, Bush TJ, Chiasson MA, Sawo D, Wright TC. HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: a prospective cohort study. Lancet 2002;359:108-13
  14. Weir HK, Thun MJ, Hankey BF, Reis LA, Howe HL, Wingo PA, et al. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst 2003;95:127